Benzoyl peroxide solution

Spl unclassified section

ACNE WASH FOR TOPICAL USE

ACNE WASH KIT FOR TOPICAL USE

Rx only

Description

Benzoyl peroxide creamy wash 4% and 8% are topical preparations containing benzoyl peroxide as the active ingredient. Benzoyl peroxide creamy wash 4% and 8% contain 4% and 8% benzoyl peroxide, respectively, in a lathering cream vehicle containing alpha olefin sulfonate, cetostearyl alcohol, glycerin, glyceryl monostearate SE, methylparaben, phosphoric acid, propylene glycol, sodium PCA, white petrolatum and purified water.

The structural formula of benzoyl peroxide is:

Structural Formula of Benzoyl Peroxide

Clinical pharmacology

The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide is believed to be responsible for its usefulness in acne.

Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.

Indications and usage

Benzoyl peroxide creamy wash 4% and 8% are indicated for use in the topical treatment of mild to moderate acne vulgaris. Benzoyl peroxide creamy wash 4% and 8% may be used as an adjunct in acne treatment regimens including antibiotics, retinoic acid products, and sulfur/ salicylic acid containing preparations.

Contraindications

Benzoyl peroxide creamy wash 4% and 8% should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product.

Precautions

General

For external use only. Avoid contact with eyes and mucous membranes. AVOID CONTACT WITH HAIR, FABRICS OR CARPETING ASBENZOYL PEROXIDE WILL CAUSE BLEACHING.

Carcinogenesis, mutagenesis, impairment of fertility

Based upon all available evidence, benzoyl peroxide is not considered to be a carcinogen. However, data from a study using mice known to be highly susceptible to cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of the findings is not known.

Pregnancy

Pregnancy Category CAnimal reproduction studies have not been conducted with benzoyl peroxide. It is not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be used by a pregnant woman only if clearly needed.

Nursing mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to a nursing woman.

Pediatric use

Safety and effectiveness in children below the age of 12 have not been established.

Adverse reactions

Contact sensitization reactions are associated with the use of topical benzoyl peroxide products and may be expected to occur in 10 to 25 of 1000 patients. The most frequent adverse reactions associated with benzoyl peroxide use are excessive erythema and peeling which may be expected to occur in 5 of 100 patients. Excessive erythema and peeling most frequently appear during the initial phase of drug use and may normally be controlled by reducing frequency of use.

Dosage and administration

Shake well before using. Wash the affected areas once a day during the first week, and twice a day thereafter as tolerated. Wet skin areas to be treated; apply benzoyl peroxide creamy wash 4% or 8%, work to a full lather, rinse thoroughly and pat dry. Frequency of use should be adjusted to obtain the desired clinical response. Clinically visible improvement will normally occur by the third week of therapy. Maximum lesion reduction may be expected after approximately eight to twelve weeks of drug use. Continuing use of the drug is normally required to maintain a satisfactory clinical response.

How supplied

Benzoyl peroxide creamy wash 4% is supplied in 170 gm (6 oz) tubes:
NDC 68462-414-38

Acne wash kit includes Benzoyl peroxide creamy wash 4% 170 gm (6 oz) and Soap-free cleanser lotion 106 ml (3.6 fl oz):
NDC 68462-548-38

Benzoyl peroxide creamy wash 8% is supplied in 170 gm (6 oz) tubes:
NDC 68462-415-38

Acne wash kit includes Benzoyl peroxide creamy wash 8% 170 gm (6 oz) and Soap-free cleanser lotion 106 ml (3.6 fl oz):
NDC 68462-549-38

Storage and handling section

Store at 15 to 30C (59 to 86F) [see USP Controlled Room Temperature].

Spl unclassified section

Manufactured by:

Glenmark Generics Ltd.
Colvale-Bardez, Goa 403 513, India

Manufactured for:

Glenmark Logo

Glenmark Generics Inc., USA
Mahwah, NJ 07430

Questions? 1 (888)721-7115
www.glenmarkgenerics.com

January 2010

Ingredients and appearance - Product information

Benzoyl peroxide solution- Benzoyl peroxide

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 68462-414
Route of Administration Topical

Active Ingredient/Active Moiety

Ingredient Name Strength
Benzoyl peroxide ( UNII: W9WZN9A0GM)( Benzoyl peroxide - UNII: W9WZN9A0GM ) 4 gin 100 g

Inactive Ingredients

Ingredient Name Code
Cetostearyl alcohol ( UNII: 2DMT128M1S)
Glycerin ( UNII: PDC6A3C0OX)
Glyceryl monostearate ( UNII: 230OU9XXE4)
Methylparaben ( UNII: A2I8C7HI9T)
Phosphoric acid ( UNII: E4GA8884NN)
Propylene glycol ( UNII: 6DC9Q167V3)
Sodium pyrrolidone carboxylate ( UNII: 469OTG57A2)
Petrolatum ( UNII: 4T6H12BN9U)
Water ( UNII: 059QF0KO0R)

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug other USA

Benzoyl peroxide solution- Benzoyl peroxide

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 68462-548
Route of Administration Topical

Active Ingredient/Active Moiety

Ingredient Name Strength
Benzoyl peroxide ( UNII: W9WZN9A0GM)( Benzoyl peroxide - UNII: W9WZN9A0GM ) 4 gin 100 g

Inactive Ingredients

Ingredient Name Code
Cetostearyl alcohol ( UNII: 2DMT128M1S)
Glycerin ( UNII: PDC6A3C0OX)
Glyceryl monostearate ( UNII: 230OU9XXE4)
Methylparaben ( UNII: A2I8C7HI9T)
Phosphoric acid ( UNII: E4GA8884NN)
Propylene glycol ( UNII: 6DC9Q167V3)
Sodium pyrrolidone carboxylate ( UNII: 469OTG57A2)
Petrolatum ( UNII: 4T6H12BN9U)
Water ( UNII: 059QF0KO0R)

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug other USA

Benzoyl peroxide solution- Benzoyl peroxide

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 68462-415
Route of Administration Topical

Active Ingredient/Active Moiety

Ingredient Name Strength
Benzoyl peroxide ( UNII: W9WZN9A0GM)( Benzoyl peroxide - UNII: W9WZN9A0GM ) 8 gin 100 g

Inactive Ingredients

Ingredient Name Code
Cetostearyl alcohol ( UNII: 2DMT128M1S)
Glycerin ( UNII: PDC6A3C0OX)
Glyceryl monostearate ( UNII: 230OU9XXE4)
Methylparaben ( UNII: A2I8C7HI9T)
Phosphoric acid ( UNII: E4GA8884NN)
Propylene glycol ( UNII: 6DC9Q167V3)
Sodium pyrrolidone carboxylate ( UNII: 469OTG57A2)
Petrolatum ( UNII: 4T6H12BN9U)
Water ( UNII: 059QF0KO0R)

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug other USA

Benzoyl peroxide solution- Benzoyl peroxide

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 68462-549
Route of Administration Topical

Active Ingredient/Active Moiety

Ingredient Name Strength
Benzoyl peroxide ( UNII: W9WZN9A0GM)( Benzoyl peroxide - UNII: W9WZN9A0GM ) 8 gin 100 g

Inactive Ingredients

Ingredient Name Code
Cetostearyl alcohol ( UNII: 2DMT128M1S)
Glycerin ( UNII: PDC6A3C0OX)
Glyceryl monostearate ( UNII: 230OU9XXE4)
Methylparaben ( UNII: A2I8C7HI9T)
Phosphoric acid ( UNII: E4GA8884NN)
Propylene glycol ( UNII: 6DC9Q167V3)
Sodium pyrrolidone carboxylate ( UNII: 469OTG57A2)
Petrolatum ( UNII: 4T6H12BN9U)
Water ( UNII: 059QF0KO0R)

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug other USA

Labeler - Glenmark Generics Inc., USA( 130597813)

Establishment

Name ID/FEI Business Operations
Glenmark Generics Inc., USA 130597813 ANALYSIS( 68462-414, 68462-548, 68462-415, 68462-549), MANUFACTURE( 68462-414, 68462-548, 68462-415, 68462-549)

4% principal display panel

4% kit principal display panel

8% principal display panel

8% kit principal display panel